Arcellx (ACLX) Total Current Liabilities (2021 - 2025)
Arcellx (ACLX) recorded quarterly Total Current Liabilities of $104.2 million in Q4 2025, down 11.99% quarter-over-quarter from $118.4 million in Q3 2025, and down 16.91% on a YoY basis from $125.4 million in Q4 2024.
Arcellx (ACLX) Total Current Liabilities (2021 - 2025) Analysis & Trends
Arcellx's Total Current Liabilities history runs 5 years deep, the most recent figure standing at $104.2 million for Q4 2025.
- In Q4 2025, Total Current Liabilities fell 16.91% year-over-year to $104.2 million; the TTM figure through Dec 2025 stood at $104.2 million (down 16.91% YoY), while the FY2025 annual figure was $104.2 million, down 16.91% from the prior year.
- Total Current Liabilities was $104.2 million for Q4 2025 at Arcellx, down from $118.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $173.1 million in Q3 2023 to a low of $14.4 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $99.0 million across 5 years, with a median of $112.5 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities surged 1051.18% in 2023, then plunged 43.45% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $14.8 million in 2021, then surged by 281.9% to $56.7 million in 2022, then soared by 108.56% to $118.2 million in 2023, then climbed by 6.06% to $125.4 million in 2024, then decreased by 16.91% to $104.2 million in 2025.
- The last three Total Current Liabilities figures came in at $104.2 million (Q4 2025), $118.4 million (Q3 2025), and $121.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 104.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 104.20 Mn |
| Sep 30, 2025 | 118.39 Mn |
| Jun 30, 2025 | 121.85 Mn |
| Mar 31, 2025 | 112.46 Mn |
| Dec 31, 2024 | 125.41 Mn |
| Sep 30, 2024 | 137.02 Mn |
| Jun 30, 2024 | 88.29 Mn |
| Mar 31, 2024 | 107.90 Mn |
| Dec 31, 2023 | 118.24 Mn |
| Sep 30, 2023 | 173.15 Mn |
| Jun 30, 2023 | 156.11 Mn |
| Mar 31, 2023 | 166.06 Mn |
| Dec 31, 2022 | 56.69 Mn |
| Sep 30, 2022 | 44.78 Mn |
| Jun 30, 2022 | 23.73 Mn |
| Mar 31, 2022 | 14.43 Mn |
| Dec 31, 2021 | 14.85 Mn |